AAAAAA

   
Results: 1-18 |
Results: 18
Decline of a visceral leishmaniasis epidemic in HIV-infected patients after the introduction of highly active antiretroviral therapy (HAART)
Authors: Lopez-Velez, R Casado, JL Pintado, V
Citation: R. Lopez-velez et al., Decline of a visceral leishmaniasis epidemic in HIV-infected patients after the introduction of highly active antiretroviral therapy (HAART), CL MICRO IN, 7(7), 2001, pp. 394-395
Relapsing visceral leishmaniasis in HIV-infected patients undergoing successful protease inhibitor therapy
Authors: Casado, JL Lopez-Velez, R Pintado, V Quereda, C Antela, A Moreno, S
Citation: Jl. Casado et al., Relapsing visceral leishmaniasis in HIV-infected patients undergoing successful protease inhibitor therapy, EUR J CL M, 20(3), 2001, pp. 202-205
Phenotypic cross-resistance to nelfinavir: The role of prior antiretroviral therapy and the number of mutations in the protease gene
Authors: Dronda, F Casado, JL Moreno, S Hertogs, K Garcia-Arata, I Antela, A Perez-Elias, MJ Ruiz, L Larder, B
Citation: F. Dronda et al., Phenotypic cross-resistance to nelfinavir: The role of prior antiretroviral therapy and the number of mutations in the protease gene, AIDS RES H, 17(3), 2001, pp. 211-215
Efficacy, tolerance, and pharmacokinetics of the combination of stavudine,nevirapine, nelfinavir, and saquinavir as salvage regimen after ritonavir or indinavir failure
Authors: Casado, JL Dronda, F Hertogs, K Sabido, R Antela, A Marti-Belda, P Dehertogh, P Moreno, S
Citation: Jl. Casado et al., Efficacy, tolerance, and pharmacokinetics of the combination of stavudine,nevirapine, nelfinavir, and saquinavir as salvage regimen after ritonavir or indinavir failure, AIDS RES H, 17(2), 2001, pp. 93-98
Mycobacterium kansasii pericarditis as a presentation of AIDS
Authors: Pintado, V Fortun, J Casado, JL Gomez-Mampaso, E
Citation: V. Pintado et al., Mycobacterium kansasii pericarditis as a presentation of AIDS, INFECTION, 29(1), 2001, pp. 48-50
Long-term outcomes of protease inhibitor-based therapy in antiretroviral treatment-naive HIV-infected injection drug users on methadone maintenance programmes
Authors: Moreno, A Perez-Elias, MJ Casado, JL Munoz, V Antela, A Dronda, F Navas, E Moreno, S
Citation: A. Moreno et al., Long-term outcomes of protease inhibitor-based therapy in antiretroviral treatment-naive HIV-infected injection drug users on methadone maintenance programmes, AIDS, 15(8), 2001, pp. 1068-1070
A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection.
Authors: de Quiros, JCLB Miro, JM Pena, JM Podzamczer, D Alberdi, JC Martinez, E Cosin, J Claramonte, X Gonzalez, J Domingo, P Casado, JL Ribera, E
Citation: Jclb. De Quiros et al., A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection., N ENG J MED, 344(3), 2001, pp. 159-167
Effectiveness and pitfalls of initial highly active antiretroviral therapyin HIV-infected patients in routine clinical practice
Authors: Moreno, A Perez-Elias, MJ Casado, JL Munoz, V Antela, A Dronda, F Navas, E Fortun, J Quereda, C Moreno, S
Citation: A. Moreno et al., Effectiveness and pitfalls of initial highly active antiretroviral therapyin HIV-infected patients in routine clinical practice, ANTIVIR TH, 5(4), 2000, pp. 243-248
Phenotypic testing predicts virological response in successive protease inhibitor-based regimens
Authors: Perez-Elias, MJ Lanier, R Munoz, V Garcia-Arata, I Casado, JL Marti-Belda, P Moreno, A Dronda, F Antela, A Marco, S Moreno, S
Citation: Mj. Perez-elias et al., Phenotypic testing predicts virological response in successive protease inhibitor-based regimens, AIDS, 14(9), 2000, pp. F95-F101
Failure of a ritonavir plus saquinavir-based rescue regimen precludes the use of protease inhibitors
Authors: Casado, JL Dronda, F Hertogs, K Antela, A Moreno, S
Citation: Jl. Casado et al., Failure of a ritonavir plus saquinavir-based rescue regimen precludes the use of protease inhibitors, AIDS, 14(4), 2000, pp. 466-468
Non-nucleoside reverse transcriptase inhibitor resistance among patients failing a nevirapine plus protease inhibitor-containing regimen
Authors: Casado, JL Hertogs, K Ruiz, L Dronda, F Van Cauwenberge, A Arno, A Garcia-Arata, I Bloor, S Bonjoch, A Blazquez, J Clotet, B Larder, B
Citation: Jl. Casado et al., Non-nucleoside reverse transcriptase inhibitor resistance among patients failing a nevirapine plus protease inhibitor-containing regimen, AIDS, 14(2), 2000, pp. F1-F7
Semiquantitative culture of subcutaneous segment for conservative diagnosis of intravascular catheter-related infection
Authors: Fortun, J Perez-Molina, JA Asensio, A Calderon, C Casado, JL Mir, N Moreno, A Guerrero, A
Citation: J. Fortun et al., Semiquantitative culture of subcutaneous segment for conservative diagnosis of intravascular catheter-related infection, J PARENT EN, 24(4), 2000, pp. 210-214
Efavirenz in HIV infection.
Authors: Casado, JL Moreno, S
Citation: Jl. Casado et S. Moreno, Efavirenz in HIV infection., N ENG J MED, 342(17), 2000, pp. 1290-1290
Percentage of adherence correlates with the risk of protease inhibitor (PI) treatment failure in HIV-infected patients
Authors: Casado, JL Sabido, R Perez-Elias, MJ Antela, A Oliva, J Dronda, F Mejia, B Fortun, J
Citation: Jl. Casado et al., Percentage of adherence correlates with the risk of protease inhibitor (PI) treatment failure in HIV-infected patients, ANTIVIR TH, 4(3), 1999, pp. 157-161
Patients failing saquinavir therapy require an early change to indinavir before HIV-1 viral load reaches high levels
Authors: Dronda, F Perez-Elias, MJ Antela, A Casado, JL Marti-Belda, P Cobo, J
Citation: F. Dronda et al., Patients failing saquinavir therapy require an early change to indinavir before HIV-1 viral load reaches high levels, ANTIVIR TH, 4(2), 1999, pp. 117-121
Incidence and risk factors for developing cytomegalovirus retinitis in HIV-infected patients receiving protease inhibitor therapy
Authors: Casado, JL Arrizabalaga, J Montes, M Marti-Belda, P Tural, C Pinilla, J Gutierrez, C Portu, J Schuurman, R Aguirrebengoa, K
Citation: Jl. Casado et al., Incidence and risk factors for developing cytomegalovirus retinitis in HIV-infected patients receiving protease inhibitor therapy, AIDS, 13(12), 1999, pp. 1497-1502
Meningoencephalitis: an unusual complication of influenza vaccine
Authors: Blanco, A Domiguez, JML Casado, JL Diaz, C
Citation: A. Blanco et al., Meningoencephalitis: an unusual complication of influenza vaccine, MED CLIN, 112(15), 1999, pp. 597-597
Zidovudine therapy protects against Salmonella bacteremia recurrence in human immunodeficiency virus-infected patients
Authors: Casado, JL Valdezate, S Calderon, C Navas, E Frutos, B Guerrero, A Martinez-Beltran, J
Citation: Jl. Casado et al., Zidovudine therapy protects against Salmonella bacteremia recurrence in human immunodeficiency virus-infected patients, J INFEC DIS, 179(6), 1999, pp. 1553-1556
Risultati: 1-18 |